-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UVn1ZSKlRajA40qEMFYWlbJKIQCq7pQedONKtQ78cYW90x9WyrUH9/8vs5+VtKZ7 sZQsdaiBG6dcSTj8zGz14Q== 0001188112-06-002424.txt : 20060809 0001188112-06-002424.hdr.sgml : 20060809 20060809171615 ACCESSION NUMBER: 0001188112-06-002424 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060809 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20060809 DATE AS OF CHANGE: 20060809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THERAGENICS CORP CENTRAL INDEX KEY: 0000795551 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 581528626 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14339 FILM NUMBER: 061018669 BUSINESS ADDRESS: STREET 1: 5203 BRISTOL INDUSTRIAL WAY CITY: BUFORD STATE: GA ZIP: 30518 BUSINESS PHONE: 7702710233 MAIL ADDRESS: STREET 1: 5203 BRISTOL INDUSTRIAL WAY CITY: BUFORD STATE: GA ZIP: 30518 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR MEDICINE INC DATE OF NAME CHANGE: 19860902 8-K 1 t11244_8k.htm FORM 8-K Form 8-K
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K
 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): August 9, 2006 (August 7, 2006)

THERAGENICS CORPORATION® 
(Exact name of Registrant as specified in its charter)


Delaware
000-15443
58-1528626
(State of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)


5203 Bristol Industrial Way
Buford, Georgia 30518
(Address of principal executive offices / Zip Code)


(770) 271-0233
(Company’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:
 
o    Written communications pursuant to Rule 425 under the Securities Act.
 
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
 
o    Pre-commencement communications pursuant to Rule 14d—2(b) under the Exchange Act.
 
o    Pre-commencement communications pursuant to Rule 13e—4(c) under the Exchange Act.
 


 
ITEM 5.02  ELECTION OF DIRECTORS

On August 7, 2006, the Board of Directors of Theragenics Corporation (the “Company”) elected Luther T. Griffith to serve a term as a Class II director that will expire at the 2009 annual meeting of stockholders. Mr. Griffith was appointed to the Audit Committee and Corporate Governance Committee of the Board of Directors.

Since 2004, Mr. Griffith has served as a director of Lifecore Biomedical, Inc., a Nasdaq-listed manufacturer of biomaterials and medical devices where he currently serves as the Chairman of the Audit Committee and serves on the Governance and Nominating Committee. Since 1994, Mr. Griffith has been President of Griffith Resources, Inc., which provides consulting and capital resources to small businesses in the process of change.

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
THERAGENICS CORPORATION
 
(Registrant)
   
Dated: August 9, 2006
By: /s/ M. Christine Jacobs
 
             M. Christine Jacobs
   
             Chief Executive Officer

 
 
 
 
 
2
 -----END PRIVACY-ENHANCED MESSAGE-----